EAC

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry

Retrieved on: 
Thursday, December 8, 2022

I would like to thank the Medical Device + Diagnostic Industry editorial board for this honor, said Lishan Aklog, M.D.

Key Points: 
  • I would like to thank the Medical Device + Diagnostic Industry editorial board for this honor, said Lishan Aklog, M.D.
  • The MD+DI team carefully evaluated medical device and diagnostics companies that rose above the ranks over the past year and selected as Medtech Company of the Year 2022 Finalists those who have made tremendous strides in 2022.
  • The finalists include industry leaders such as Abbott Laboratories, Medtronic and ResMed, as well as newer groundbreaking companies such as BioIntelliSense and Senseonics.
  • Lucid Diagnostics Inc. (Nasdaq: LUCD) is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM).

Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research

Retrieved on: 
Thursday, December 1, 2022

Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), today announced that Suman M. Verma, M.D., Ph.D., Lucids Chief Scientific Officer, presented real-world data on its EsoCheck Cell Collection Device (EsoCheck) at the American Association for Cancer Researchs (AACR) Special Conference: Precision Prevention, Early Detection, and Interception of Cancer.

Key Points: 
  • Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), today announced that Suman M. Verma, M.D., Ph.D., Lucids Chief Scientific Officer, presented real-world data on its EsoCheck Cell Collection Device (EsoCheck) at the American Association for Cancer Researchs (AACR) Special Conference: Precision Prevention, Early Detection, and Interception of Cancer.
  • Millions of patients with GERD are at risk of developing esophageal precancer and a highly lethal form of esophageal cancer (EAC).
  • Over 80% of EAC patients die within five years of diagnosis, making it the second most lethal cancer in the U.S.
  • Lucid Diagnostics Inc. (Nasdaq: LUCD) is a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM).

Allied Electronics & Automation Offers Schneider Electric's new Altivar ATS480 Soft Starters for Industrial Automation Applications

Retrieved on: 
Wednesday, November 9, 2022

FORT WORTH, Texas, Nov. 9, 2022 /PRNewswire/ -- Allied Electronics & Automation, a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of product and service solutions, is now stocking Schneider Electric's new Altivar ATS480 soft starters, which are designed to support widespread digitization efforts in the industrial automation industry.

Key Points: 
  • FORT WORTH, Texas, Nov. 9, 2022 /PRNewswire/ -- Allied Electronics & Automation , a trading brand of RS Group plc (LSE: RS1), a global omni-channel provider of product and service solutions, is now stocking Schneider Electric's new Altivar ATS480 soft starters, which are designed to support widespread digitization efforts in the industrial automation industry.
  • For more information about Schneider Electric's new Altivar ATS480 soft starters, please visit the product page .
  • For assistance identifying, deploying, and maintaining Schneider Electric solutions in your industrial automation applications, please contactyour local Allied representative at 1.866.433.5722 or reach out to Allied's technical support team .
  • For more information about Allied Electronics & Automation, please visit www.alliedelec.com/ or connect with us via social media on Facebook , Twitter , and LinkedIn .

New Data Demonstrate that the Utilization of TissueCypher® Barrett’s Esophagus Test Results Can Significantly Improve the Management of Low-Grade Dysplasia in Patients with Barrett’s Esophagus over the Standard of Care Alone

Retrieved on: 
Tuesday, October 25, 2022

A diagnosis of low-grade dysplasia in Barretts esophagus warrants expert pathology review, as these patients may have a significant risk of developing esophageal cancer.

Key Points: 
  • A diagnosis of low-grade dysplasia in Barretts esophagus warrants expert pathology review, as these patients may have a significant risk of developing esophageal cancer.
  • The use of TissueCypher test results can reduce inconsistencies in management decisions for Barretts esophagus patients with low-grade dysplasia.
  • In the other arm, patients were managed by the current standard of care with additional guidance from TissueCypher test results.
  • The TissueCypher Barretts Esophagus test is Castles precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barretts esophagus (BE).

Key Industry Players to Discuss IoT, Automotive, Wireless, and Supply Chain Trends and Opportunities at EAC 2022

Retrieved on: 
Monday, October 17, 2022

Gartner Inc., for one, reduced its earlier forecast of 13.6% global semiconductor revenue growth this year to just 7.4%.

Key Points: 
  • Gartner Inc., for one, reduced its earlier forecast of 13.6% global semiconductor revenue growth this year to just 7.4%.
  • The market research firm, however, noted that this down cycle is not new and has happened many times before.
  • Mainly driving this growth is strong demand for automotive semiconductors and new government funding and incentive programs in multiple regions.
  • Highlighting such trends and innovations, the inaugural Electronics Asia Conference (EAC) 2022, scheduled for October 18-20, 2022, will feature some of the leading semiconductor companies discussing new applications and markets driving the technology developments in the semiconductor industry.

Results from a Randomized Controlled Trial Show That TissueCypher® Barrett’s Esophagus Test Results Can Significantly Improve the Accuracy of Risk Assessments and Adherence to Guideline-Recommended Patient Management

Retrieved on: 
Thursday, October 13, 2022

TissueCypher is Castles precision medicine test designed to predict progression to HGD and/or EAC within five years for patients diagnosed with BE.

Key Points: 
  • TissueCypher is Castles precision medicine test designed to predict progression to HGD and/or EAC within five years for patients diagnosed with BE.
  • Importantly, subsequent to receiving test results and making their assessment, the intervention group was also more likely to adhere to guideline-recommended management strategies.
  • Quality-of-care scores improved significantly across all patient cases after physicians were given the TissueCypher test results.
  • The TissueCypher Barretts Esophagus test is Castles precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barretts esophagus (BE).

No Bull Employee Charities Give Donation to Phoenix Children's Hospital Foundation

Retrieved on: 
Monday, September 12, 2022

PHOENIX, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Phoenix Children's Hospital Foundation received a significant donation from No Bull Employee Charities.The money was raised from voluntary payroll donations of participating employees at Earnhardt Auto Centers.

Key Points: 
  • PHOENIX, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Phoenix Children's Hospital Foundation received a significant donation from No Bull Employee Charities.The money was raised from voluntary payroll donations of participating employees at Earnhardt Auto Centers.
  • "Many people don't realize just how much free care is needed at the Phoenix Children's Hospital," said Jayla Hall, Media & Promotions Coordinator, Earnhardt Auto Centers, in discussing the "No Bull Employee Charities - Employee Contributions" initiative from Earnhardt Auto Centers.
  • The Phoenix Children's Hospital Foundation assists with raising the money needed for pediatric care.
  • The "No Bull Employee Charities - Employee Contributions" program chooses four charities each year where quarterly donations will be sent; voted on by Earnhardt employees.The donation to the Phoenix Children's Hospital Foundation represented the money raised from voluntary payroll deductions by Earnhardt Employees in the months of April, May and June, 2022.

Electronics Asia Conference 2022 Puts Spotlight on IoT, Automotive Electronics, Wireless Technologies, and the Semiconductor Supply Chain

Retrieved on: 
Friday, August 26, 2022

While industry demand was driven by the industrial and automotive industries in 2021, IDC expects 5G, consumer electronics, wireless technologies, datacenters, and wearables will continue drive demand this year.

Key Points: 
  • While industry demand was driven by the industrial and automotive industries in 2021, IDC expects 5G, consumer electronics, wireless technologies, datacenters, and wearables will continue drive demand this year.
  • To put the spotlight on the key players and the latest technologies and trends in the electronics and semiconductor industry, AspenCore, the publisher of EETimes Asia, EETimes India, and EDN Asia, will hold the inaugural Electronics Asia Conference (EAC) 2022 on October 18-20, 2022.
  • With the theme "Gearing Up for Growth: Electronics and Semiconductor Technologies Driving Industry Developments in Asia," EAC 2022 will put the spotlight on industries and applications including IoT, wireless technologies, automotive electronics, and the supply chain.
  • Our brands include EE Times, Electronic Products, EPSNews, ESM China, IoT Times, Power Electronics News, EDN, EEWeb, Electro Schematics, Elektroda.pl, Embedded.com, Planet Analog, and more.

Eastern Arizona College Selects Anthology to Bring Dynamic Data-Informed Experiences to Students and Faculty

Retrieved on: 
Monday, August 22, 2022

BOCA RATON, Fla., Aug. 22, 2022 /PRNewswire/ -- Anthology, a leading provider of education solutions that support the entire learner lifecycle, today announced that Eastern Arizona College (EAC) will adopt several Anthology solutions to create a more sustainable, modern user experience, including Anthology Student; Finance & Human Capital Management (HCM); Payroll; and Occupation Insight.

Key Points: 
  • We are committed to providing data-driven solutions that streamline and personalize operations while also helping students achieve their individual goals," said Jim Milton, Chairman and Chief Executive Officer at Anthology.
  • "EAC understands that technology is at the forefront of creating truly intelligent experiences for students and we look forward to partnering with them in their next phase of growth."
  • "Partnering with Anthology will put the modern, cloud-based tools that our staff and students need to succeed right at their fingertips," said Dr. Susan Wood, Vice President of Academic and Student Affairs at Eastern Arizona College.
  • Anthology offers the largest EdTech ecosystem on a global scale for education, supporting more than 150 million users in 80 countries.

Richard Mortellaro Appointed as President and CEO of Eutelsat America Corp.

Retrieved on: 
Monday, August 22, 2022

Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) announced today that Richard Mortellaro has been appointed to the position of President and CEO of Eutelsat America Corp. (EAC).

Key Points: 
  • Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) announced today that Richard Mortellaro has been appointed to the position of President and CEO of Eutelsat America Corp. (EAC).
  • Eutelsat America Corp., a subsidiary of Eutelsat Communications, delivers communications services and solutions to US Government and Military customers around the globe in support of national security missions.
  • Prior to joining Eutelsat, Richard was Senior Vice President of Sales, Marketing and Fixed Satellite Services Business Development Activities at EchoStar Satellite Services, LLC.
  • Mortellaro noted: I look forward to leading EAC during this exciting time in our industry as we execute Eutelsats vision and strategy.